Atlas Trials

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Clinical trial NCT04383210 · TERMINATED

Trial details

NCT number
NCT04383210
Sponsor
Elevation Oncology
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced Solid TumorMetastatic Solid TumorPancreatic CancerLung CancerHead and Neck CancerBreast CancerKidney CancerColorectal CancerBladder CancerOvarian CancerSarcomaGallbladder Cancer
Start date
2020-09-29
Primary completion
2024-02-28
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.